These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

467 related items for PubMed ID: 16607286

  • 1. A crucial function of PDGF in TGF-beta-mediated cancer progression of hepatocytes.
    Gotzmann J, Fischer AN, Zojer M, Mikula M, Proell V, Huber H, Jechlinger M, Waerner T, Weith A, Beug H, Mikulits W.
    Oncogene; 2006 May 25; 25(22):3170-85. PubMed ID: 16607286
    [Abstract] [Full Text] [Related]

  • 2. PDGF essentially links TGF-beta signaling to nuclear beta-catenin accumulation in hepatocellular carcinoma progression.
    Fischer AN, Fuchs E, Mikula M, Huber H, Beug H, Mikulits W.
    Oncogene; 2007 May 17; 26(23):3395-405. PubMed ID: 17130832
    [Abstract] [Full Text] [Related]

  • 3. Integration of Ras subeffector signaling in TGF-beta mediated late stage hepatocarcinogenesis.
    Fischer AN, Herrera B, Mikula M, Proell V, Fuchs E, Gotzmann J, Schulte-Hermann R, Beug H, Mikulits W.
    Carcinogenesis; 2005 May 17; 26(5):931-42. PubMed ID: 15705598
    [Abstract] [Full Text] [Related]

  • 4. beta-Catenin and TGFbeta signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition.
    Eger A, Stockinger A, Park J, Langkopf E, Mikula M, Gotzmann J, Mikulits W, Beug H, Foisner R.
    Oncogene; 2004 Apr 08; 23(15):2672-2680. PubMed ID: 14755243
    [Abstract] [Full Text] [Related]

  • 5. Thyroid transcription factor-1 inhibits transforming growth factor-beta-mediated epithelial-to-mesenchymal transition in lung adenocarcinoma cells.
    Saito RA, Watabe T, Horiguchi K, Kohyama T, Saitoh M, Nagase T, Miyazono K.
    Cancer Res; 2009 Apr 01; 69(7):2783-91. PubMed ID: 19293183
    [Abstract] [Full Text] [Related]

  • 6. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
    Schniewind B, Groth S, Sebens Müerköster S, Sipos B, Schäfer H, Kalthoff H, Fändrich F, Ungefroren H.
    Oncogene; 2007 Jul 19; 26(33):4850-62. PubMed ID: 17297450
    [Abstract] [Full Text] [Related]

  • 7. The proto-oncoprotein c-Fos negatively regulates hepatocellular tumorigenesis.
    Mikula M, Gotzmann J, Fischer AN, Wolschek MF, Thallinger C, Schulte-Hermann R, Beug H, Mikulits W.
    Oncogene; 2003 Oct 02; 22(43):6725-38. PubMed ID: 14555986
    [Abstract] [Full Text] [Related]

  • 8. Autocrine production of TGF-beta confers resistance to apoptosis after an epithelial-mesenchymal transition process in hepatocytes: Role of EGF receptor ligands.
    Del Castillo G, Murillo MM, Alvarez-Barrientos A, Bertran E, Fernández M, Sánchez A, Fabregat I.
    Exp Cell Res; 2006 Sep 10; 312(15):2860-71. PubMed ID: 16828470
    [Abstract] [Full Text] [Related]

  • 9. Transcriptome profiling of a TGF-beta-induced epithelial-to-mesenchymal transition reveals extracellular clusterin as a target for therapeutic antibodies.
    Lenferink AE, Cantin C, Nantel A, Wang E, Durocher Y, Banville M, Paul-Roc B, Marcil A, Wilson MR, O'Connor-McCourt MD.
    Oncogene; 2010 Feb 11; 29(6):831-44. PubMed ID: 19935703
    [Abstract] [Full Text] [Related]

  • 10. Transforming growth factor-beta-mediated tumor necrosis factor-related apoptosis-inducing ligand expression and apoptosis in hepatoma cells requires functional cooperation between Smad proteins and activator protein-1.
    Herzer K, Grosse-Wilde A, Krammer PH, Galle PR, Kanzler S.
    Mol Cancer Res; 2008 Jul 11; 6(7):1169-77. PubMed ID: 18644981
    [Abstract] [Full Text] [Related]

  • 11. Epithelial-mesenchymal transition in ovarian cancer progression: a crucial role for the endothelin axis.
    Bagnato A, Rosanò L.
    Cells Tissues Organs; 2007 Jul 11; 185(1-3):85-94. PubMed ID: 17587812
    [Abstract] [Full Text] [Related]

  • 12. Autocrine stimulatory mechanism by transforming growth factor beta in human hepatocellular carcinoma.
    Matsuzaki K, Date M, Furukawa F, Tahashi Y, Matsushita M, Sakitani K, Yamashiki N, Seki T, Saito H, Nishizawa M, Fujisawa J, Inoue K.
    Cancer Res; 2000 Mar 01; 60(5):1394-402. PubMed ID: 10728705
    [Abstract] [Full Text] [Related]

  • 13. The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells.
    Deckers M, van Dinther M, Buijs J, Que I, Löwik C, van der Pluijm G, ten Dijke P.
    Cancer Res; 2006 Feb 15; 66(4):2202-9. PubMed ID: 16489022
    [Abstract] [Full Text] [Related]

  • 14. Expression of transforming growth factor-beta1 and transforming growth factor-beta receptors in hepatocellular carcinoma and dysplastic nodules.
    Paik SY, Park YN, Kim H, Park C.
    Mod Pathol; 2003 Jan 15; 16(1):86-96. PubMed ID: 12527718
    [Abstract] [Full Text] [Related]

  • 15. Targeting stromal cells for the treatment of platelet-derived growth factor C-induced hepatocellular carcinogenesis.
    Campbell JS, Johnson MM, Bauer RL, Hudkins KL, Gilbertson DG, Riehle KJ, Yeh MM, Alpers CE, Fausto N.
    Differentiation; 2007 Nov 15; 75(9):843-52. PubMed ID: 17999742
    [Abstract] [Full Text] [Related]

  • 16. Transforming growth factor-beta induces epithelial to mesenchymal transition by down-regulation of claudin-1 expression and the fence function in adult rat hepatocytes.
    Kojima T, Takano K, Yamamoto T, Murata M, Son S, Imamura M, Yamaguchi H, Osanai M, Chiba H, Himi T, Sawada N.
    Liver Int; 2008 Apr 15; 28(4):534-45. PubMed ID: 18031476
    [Abstract] [Full Text] [Related]

  • 17. Hypotheses on the role of transforming growth factor-beta in the onset and progression of hepatocellular carcinoma.
    Dooley S, Weng H, Mertens PR.
    Dig Dis; 2009 Apr 15; 27(2):93-101. PubMed ID: 19546546
    [Abstract] [Full Text] [Related]

  • 18. Platelet derived growth factor B and epithelial mesenchymal transition of peritoneal mesothelial cells.
    Patel P, West-Mays J, Kolb M, Rodrigues JC, Hoff CM, Margetts PJ.
    Matrix Biol; 2010 Mar 15; 29(2):97-106. PubMed ID: 19896531
    [Abstract] [Full Text] [Related]

  • 19. Platelet-derived growth factor and transforming growth factor-beta modulate the expression of matrix metalloproteinases and migratory function of human airway smooth muscle cells.
    Ito I, Fixman ED, Asai K, Yoshida M, Gounni AS, Martin JG, Hamid Q.
    Clin Exp Allergy; 2009 Sep 15; 39(9):1370-80. PubMed ID: 19522858
    [Abstract] [Full Text] [Related]

  • 20. ILEI requires oncogenic Ras for the epithelial to mesenchymal transition of hepatocytes and liver carcinoma progression.
    Lahsnig C, Mikula M, Petz M, Zulehner G, Schneller D, van Zijl F, Huber H, Csiszar A, Beug H, Mikulits W.
    Oncogene; 2009 Feb 05; 28(5):638-50. PubMed ID: 19015638
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.